BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 16041642)

  • 41. Effects of St. John's wort supplementation on ibuprofen pharmacokinetics.
    Bell EC; Ravis WR; Lloyd KB; Stokes TJ
    Ann Pharmacother; 2007 Feb; 41(2):229-34. PubMed ID: 17284505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glutamate-induced cell death in neuronal HT22 cells is attenuated by extracts from St. John's wort (Hypericum perforatum L.).
    Breyer A; Elstner M; Gillessen T; Weiser D; Elstner E
    Phytomedicine; 2007 Apr; 14(4):250-5. PubMed ID: 17346956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and evaluation of methods for determination of naphthodianthrones and flavonoids in St. John's wort.
    Williams FB; Sander LC; Wise SA; Girard J
    J Chromatogr A; 2006 May; 1115(1-2):93-102. PubMed ID: 16554056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Over-the-counter psychotropics: a review of melatonin, St John's wort, valerian, and kava-kava.
    Heiligenstein E; Guenther G
    J Am Coll Health; 1998 May; 46(6):271-6. PubMed ID: 9609974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].
    Röder C; Schaefer M; Leucht S
    Fortschr Neurol Psychiatr; 2004 Jun; 72(6):330-43. PubMed ID: 15211398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Herbal drug quality and phytochemical composition of Hypericum perforatum L. affected by ash yellows phytoplasma infection.
    Bruni R; Pellati F; Bellardi MG; Benvenuti S; Paltrinieri S; Bertaccini A; Bianchi A
    J Agric Food Chem; 2005 Feb; 53(4):964-8. PubMed ID: 15713006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system.
    Simmen U; Burkard W; Berger K; Schaffner W; Lundstrom K
    J Recept Signal Transduct Res; 1999; 19(1-4):59-74. PubMed ID: 10071750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin E reduces antidepressant-related beta-adrenoceptor down-regulation in cultured cells. Comparable effects on St. John's wort and tricyclic antidepressant treatment.
    De Marchis GM; Bürgi S; Kientsch U; Honegger UE
    Planta Med; 2006 Dec; 72(15):1436-7. PubMed ID: 17109256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. St John's wort and depression: slight efficacy at best, many drug interactions.
    Prescrire Int; 2004 Oct; 13(73):187-92. PubMed ID: 15499702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test.
    Butterweck V; Jürgenliemk G; Nahrstedt A; Winterhoff H
    Planta Med; 2000 Feb; 66(1):3-6. PubMed ID: 10705724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations.
    Draves AH; Walker SE
    Can J Clin Pharmacol; 2003; 10(3):114-8. PubMed ID: 14506510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the synaptosomal uptake inhibition of serotonin by St John's wort products.
    Schulte-Löbbert S; Holoubek G; Müller WE; Schubert-Zsilavecz M; Wurglics M
    J Pharm Pharmacol; 2004 Jun; 56(6):813-8. PubMed ID: 15231048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytotoxic potential of valerian constituents and valerian tinctures.
    Bos R; Hendriks H; Scheffer JJ; Woerdenbag HJ
    Phytomedicine; 1998 May; 5(3):219-25. PubMed ID: 23195845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative determination of valepotriates from Valeriana native to South Brazil.
    Silva AL; Rech SB; von Poser GL
    Planta Med; 2002 Jun; 68(6):570-2. PubMed ID: 12094311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do other Hypericum species have medical potential as St. John's wort (Hypericum perforatum)?
    Stojanović G; Ðorđević A; Šmelcerović A
    Curr Med Chem; 2013; 20(18):2273-95. PubMed ID: 23521674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurochemical studies with St. John's wort in vitro.
    Simmen U; Higelin J; Berger-Büter K; Schaffner W; Lundstrom K
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S137-42. PubMed ID: 11518063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibitory effects of St. John's Wort on inflammation: ignored potential of a popular herb.
    Olajide OA
    J Diet Suppl; 2009; 6(1):28-32. PubMed ID: 22435352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Quantitative analysis of active substances in St. John's wort (Hypericum perforatum L.) by the high performance liquid chromatography method].
    Kazlauskas S; Bagdonaite E
    Medicina (Kaunas); 2004; 40(10):975-81. PubMed ID: 15516821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. St. John's Wort reduces neuropathic pain through a hypericin-mediated inhibition of the protein kinase Cgamma and epsilon activity.
    Galeotti N; Vivoli E; Bilia AR; Vincieri FF; Ghelardini C
    Biochem Pharmacol; 2010 May; 79(9):1327-36. PubMed ID: 20045676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of supercritical fluid extracts of St. John's wort (Hypericum perforatum L.) by HPLC-MS and GC-MS.
    Seger C; Römpp H; Sturm S; Haslinger E; Schmidt PC; Hadacek F
    Eur J Pharm Sci; 2004 Mar; 21(4):453-63. PubMed ID: 14998575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.